Q32 Bio (QTTB) Net Cash Flow (QoQ) (2017 - 2026)
Q32 Bio (QTTB) Net Cash Flow (QoQ) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Q32 Bio |
167.59 Mn |
116.84 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
430.73% |
| Dec 31, 2025 |
87.19% |
| Sep 30, 2025 |
45.61% |
| Jun 30, 2025 |
14.67% |
| Mar 31, 2025 |
-12.32% |
| Dec 31, 2024 |
-29.48% |
| Sep 30, 2024 |
51.91% |
| Jun 30, 2024 |
-121.02% |
| Mar 31, 2024 |
897.93% |
| Dec 31, 2023 |
-165.67% |
| Sep 30, 2023 |
242.72% |
| Jun 30, 2023 |
9.09% |
| Mar 31, 2023 |
-36.07% |
| Dec 31, 2022 |
93.10% |
| Sep 30, 2022 |
-84.21% |
| Jun 30, 2022 |
-152.30% |
| Mar 31, 2022 |
943.44% |
| Dec 31, 2021 |
164.60% |
| Sep 30, 2021 |
-272.18% |
| Jun 30, 2021 |
110.53% |
